But if you experience sleep apnea – where your breathing stops and starts through the night – you might need extra help to get the best rest possible. But what is a sleep apnea mask?

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

Sleep apnea, a widespread health issue, causes breathing interruptions during sleep, leading to oxygen deprivation and various health problems. It manifests in obstructive, central, and mixed forms.

It is rare that patients’ signs and symptoms perfectly match the textbook definition ... type of sleep disorder that regularly escapes clinicians’ observation is obstructive sleep apnea.

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...

The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...

In the trial that Lilly, the drug's manufacturer, submitted in April to the FDA, scientists reported that the drug helped people who were overweight or obese with sleep apnea reduce a standard ...

Discover the first FDA-approved weight loss medication for obstructive sleep apnea, Zepbound by Eli Lilly. Learn how it can reduce apnea events and CPAP market.

The definition of sleep deprivation can vary ... including primary insomnia, narcolepsy, sleep apnea, and jet lag. It can also be caused by poor sleep hygiene, including the consumption of ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved ...

The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly's Zepbound ...